These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
108 related articles for article (PubMed ID: 7169827)
1. [In vivo determination of the protective properties of immunologic preparations of tick-borne encephalitis virus]. Nawrocka E; Bednarz K Med Dosw Mikrobiol; 1982; 34(3-4):167-75. PubMed ID: 7169827 [No Abstract] [Full Text] [Related]
2. Evaluation of tick-borne encephalitis DNA vaccines in monkeys. Schmaljohn C; Custer D; VanderZanden L; Spik K; Rossi C; Bray M Virology; 1999 Oct; 263(1):166-74. PubMed ID: 10544091 [TBL] [Abstract][Full Text] [Related]
3. Studies on the immunizing potency of tick-borne encephalitis vaccines. Gall W Acta Microbiol Pol A; 1973; 5(3):279-85. PubMed ID: 4769562 [No Abstract] [Full Text] [Related]
4. Chimeric Langat/Dengue viruses protect mice from heterologous challenge with the highly virulent strains of tick-borne encephalitis virus. Pletnev AG; Karganova GG; Dzhivanyan TI; Lashkevich VA; Bray M Virology; 2000 Aug; 274(1):26-31. PubMed ID: 10936085 [TBL] [Abstract][Full Text] [Related]
5. [Isolation of new strains of tick-borne encephalitis virus in the Białoeieza Forest]. Bednarz K; Nawrocka E; Sadowski W; Zukowski K Przegl Epidemiol; 1984; 38(1):3-10. PubMed ID: 6739833 [No Abstract] [Full Text] [Related]
6. [Genetic immunization against tick-borne encephalitis virus]. Mitrofanova EE; Bakhvalova VN; Dobrikova EIu; Pap VA; Morozova OV Mol Biol (Mosk); 1997; 31(3):403-6. PubMed ID: 9297083 [No Abstract] [Full Text] [Related]
7. A synthetic peptide based on the NS1 non-structural protein of tick-borne encephalitis virus induces a protective immune response against fatal encephalitis in an experimental animal model. Volpina OM; Volkova TD; Koroev DO; Ivanov VT; Ozherelkov SV; Khoretonenko MV; Vorovitch MF; Stephenson JR; Timofeev AV Virus Res; 2005 Sep; 112(1-2):95-9. PubMed ID: 16022903 [TBL] [Abstract][Full Text] [Related]
8. Biological properties of strains of tick-borne encephalitis virus isolated in the natural foci of the eastern part of the Russian plain. Pchelkina AA; Medvedeva GI J Hyg Epidemiol Microbiol Immunol; 1984; 28(1):41-52. PubMed ID: 6715874 [TBL] [Abstract][Full Text] [Related]
9. Intranasal immunization with inactivated tick-borne encephalitis virus and the antigenic peptide 89-119 protects mice against intraperitoneal challenge. Goncharova E; Ryzhikov E; Poryvaev V; Bulychev L; Karpyshev N; Maksyutov A; Ryzhikov AB Int J Med Microbiol; 2006 May; 296 Suppl 40():195-201. PubMed ID: 16545605 [TBL] [Abstract][Full Text] [Related]
10. A study of systems for delivering antigens and plasmid DNA for intranasal immunization against tick-borne encephalitis virus. Goncharova EP; Ryzhikov AB; Bulychev LE; Sizov AA; Lebedev LR; Poryvaev VD; Karpenko LI; Il'ichev AA Wien Klin Wochenschr; 2002 Jul; 114(13-14):630-5. PubMed ID: 12422616 [TBL] [Abstract][Full Text] [Related]
11. Immunization with recombinant vaccinia viruses expressing structural and part of the nonstructural region of tick-borne encephalitis virus cDNA protect mice against lethal encephalitis. Dmitriev IP; Khromykh AA; Ignatyev GM; Gainullina MN; Ageenko VA; Dryga SA; Vorobyeva MS; Sandakhchiev LS J Biotechnol; 1996 Jan; 44(1-3):97-103. PubMed ID: 8717392 [TBL] [Abstract][Full Text] [Related]
12. Safety evaluation of chimeric Langat/Dengue 4 flavivirus, a live vaccine candidate against tick-borne encephalitis. Pripuzova NS; Tereshkina NV; Gmyl LV; Dzhivanyan TI; Rumyantsev AA; Romanova LIu; Mustafina AN; Lashkevich VA; Karganova GG J Med Virol; 2009 Oct; 81(10):1777-85. PubMed ID: 19697399 [TBL] [Abstract][Full Text] [Related]
13. [Metaanalysis of the efficiency of use of immunoglobulin preparations for the postexposure prophylaxis against tick-borne encephalitis in Russia]. Pen'evskaia NA; Rudakov NV; Agafonov AL Med Parazitol (Mosk); 2010; (3):58-63. PubMed ID: 20873186 [No Abstract] [Full Text] [Related]
14. [A comparison of the protective properties of preparations of the virion and nonvirion ("soluble") antigens of the tick-borne encephalitis virus]. Liapustin VN; Pivanova GP; Karavanov AS; Lashkevich VA Vopr Virusol; 1991; 36(6):498-500. PubMed ID: 1785186 [TBL] [Abstract][Full Text] [Related]
15. Infectious cDNA clone of attenuated Langat tick-borne flavivirus (strain E5) and a 3' deletion mutant constructed from it exhibit decreased neuroinvasiveness in immunodeficient mice. Pletnev AG Virology; 2001 Apr; 282(2):288-300. PubMed ID: 11289811 [TBL] [Abstract][Full Text] [Related]
16. [Studies on the transmission of tick-borne encephalitis virus by the tick, Dermacentor pictus (Herm)]. Wróblewska-Mularczykowa ; Zukowski K; Nawrocka E Med Dosw Mikrobiol; 1972; 24(2):133-40. PubMed ID: 5035824 [No Abstract] [Full Text] [Related]
17. Tick-borne encephalitis vaccines: past and present. Zent O; Bröker M Expert Rev Vaccines; 2005 Oct; 4(5):747-55. PubMed ID: 16221075 [TBL] [Abstract][Full Text] [Related]
18. A tick-borne encephalitis vaccine without human serum albumin as stabilizer. Bröker M; Zent O Vaccine; 2005 Dec; 23(50):5699. PubMed ID: 16226355 [No Abstract] [Full Text] [Related]
19. Two severe cases of tick-borne encephalitis despite complete active vaccination--the significance of neutralizing antibodies. Bender A; Jäger G; Scheuerer W; Feddersen B; Kaiser R; Pfister HW J Neurol; 2004 Mar; 251(3):353-4. PubMed ID: 15015020 [No Abstract] [Full Text] [Related]
20. [Effect of purification and inactivation of brain tissue culture preparations of tick-borne encephalitis virus on its antigenic and immunogenic components]. Nawrocka E; Bednarz K Med Dosw Mikrobiol; 1980; 32(1):43-53. PubMed ID: 7412444 [No Abstract] [Full Text] [Related] [Next] [New Search]